Patents by Inventor Jay Weinstein

Jay Weinstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4540579
    Abstract: Disclosed are 6-(1'-hydroxyethyl)-2-[(R)-amino acid alkyl]penem-3-carboxylic acids and salts thereof having an absolute stereochemisty of 5R,6S,8R. The compounds are useful and potent antibacterial agents and can be formulated into a variety of forms suitable for oral, parenteral or topical use.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: September 10, 1985
    Assignee: Schering Corporation
    Inventors: Adriano Afonso, Jay Weinstein
  • Patent number: 4540580
    Abstract: Disclosed are 6-(1'-hydroxyethyl)-2-[(1'R)-1'-aminoalkyl]penem-3-carboxylic acids and salts and esters thereof. The compounds are useful and potent antibacterial agents and can be formulated into a variety of forms suitable for oral, parenteral or topical use.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: September 10, 1985
    Assignee: Schering Corporation
    Inventors: Adriano Afonso, Jay Weinstein
  • Patent number: 4389398
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side affects.
    Type: Grant
    Filed: August 24, 1978
    Date of Patent: June 21, 1983
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay A. Waitz, Mae Counelis, Jay Weinstein
  • Patent number: 4110439
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side effects.
    Type: Grant
    Filed: December 20, 1976
    Date of Patent: August 29, 1978
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay A. Waitz, Mae Counelis, Jay Weinstein
  • Patent number: 4049796
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side effects.
    Type: Grant
    Filed: October 1, 1975
    Date of Patent: September 20, 1977
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay Allan Waitz, Mae Counelis, Jay Weinstein